169 related articles for article (PubMed ID: 6982917)
21. Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.
Metwali A; Blum A; Mathew R; Sandor M; Lynch RG; Weinstock JV
Cell Immunol; 1993 Jun; 149(1):11-23. PubMed ID: 8099848
[TBL] [Abstract][Full Text] [Related]
22. Alloreactive T cells from individual soft agar colonies specific for guinea pig Ia antigens. I. Production and initial characterization.
Malek TR; Clark RB; Shevach EM
J Immunol; 1981 Aug; 127(2):616-21. PubMed ID: 6166679
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporin A inhibits IL 2-driven proliferation of human alloactivated T cells.
Buurman WA; Ruers TJ; Daemen IA; van der Linden CJ; Groenewegen G
J Immunol; 1986 Jun; 136(11):4035-9. PubMed ID: 2939138
[TBL] [Abstract][Full Text] [Related]
24. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporin A and prednisolone do not inhibit the expression of high-affinity receptors for interleukin 2.
Bloemena E; Van Oers MH; Weinreich S; Schellekens PT
Clin Exp Immunol; 1988 Feb; 71(2):308-13. PubMed ID: 2832109
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 10 protects activated human T lymphocytes against growth factor withdrawal-induced cell death but only anti-fas antibody can prevent activation-induced cell death.
Pawelec G; Hambrecht A; Rehbein A; Adibzadeh M
Cytokine; 1996 Dec; 8(12):877-81. PubMed ID: 9050744
[TBL] [Abstract][Full Text] [Related]
27. Functional interaction between TGF-beta and IL-12 in human primary allogeneic cytotoxicity and proliferative response.
Pardoux C; Asselin-Paturel C; Chehimi J; Gay F; Mami-Chouaib F; Chouaib S
J Immunol; 1997 Jan; 158(1):136-43. PubMed ID: 8977184
[TBL] [Abstract][Full Text] [Related]
28. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
29. Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes.
Corrigall VM; Solau-Gervais E; Panayi GS
Arthritis Rheum; 2000 Jul; 43(7):1606-15. PubMed ID: 10902766
[TBL] [Abstract][Full Text] [Related]
30. The inhibitory effect of cyclophosphamide-induced MAC-1+ natural suppressor cells on IL-2 and IL-4 utilization in MLR.
Brooks JC; Hoskin DW
Transplantation; 1994 Nov; 58(10):1096-103. PubMed ID: 7974716
[TBL] [Abstract][Full Text] [Related]
31. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
Han SB; Park SH; Jeon YJ; Kim YK; Kim HM; Yang KH
J Pharmacol Exp Ther; 2001 Nov; 299(2):415-25. PubMed ID: 11602650
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine inhibits macrophage-mediated antigen presentation.
Palay DA; Cluff CW; Wentworth PA; Ziegler HK
J Immunol; 1986 Jun; 136(12):4348-53. PubMed ID: 3486899
[TBL] [Abstract][Full Text] [Related]
33. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of the murine autologous mixed lymphocyte reaction. I. Characterization of the stimulator cells and their recognition sites].
Ishida Y
Hokkaido Igaku Zasshi; 1982 Sep; 57(5):614-23. PubMed ID: 6983996
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporin A inhibits initiation but not progression of human T cell proliferation triggered by phorbol esters and calcium ionophores.
Kumagai N; Benedict SH; Mills GB; Gelfand EW
J Immunol; 1988 Dec; 141(11):3747-52. PubMed ID: 3263432
[TBL] [Abstract][Full Text] [Related]
37. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.
Klyushnenkova E; Mosca JD; Zernetkina V; Majumdar MK; Beggs KJ; Simonetti DW; Deans RJ; McIntosh KR
J Biomed Sci; 2005; 12(1):47-57. PubMed ID: 15864738
[TBL] [Abstract][Full Text] [Related]
38. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
39. Increased production of Kurloff cells and accompanying lymphocyte subset changes in immunized guinea-pigs treated with cyclophosphamide and cyclosporin A.
Thomson AW; McPhee CA; Sewell HF
Immunology; 1988 Mar; 63(3):477-82. PubMed ID: 3350582
[TBL] [Abstract][Full Text] [Related]
40. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
Zhou L; Ritchie D; Wang EY; Barbone AG; Argentieri D; Lau CY
J Immunol; 1994 Dec; 153(11):5026-37. PubMed ID: 7963563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
